KCT0005187
Recruiting
未知
Safety and efficacy of abluminal biodegradable polymer sirolimus-eluting coronary stents in patients with acute coronary syndrome: a single-center, prospective, observational trial
Yonsei University Health System, Yongin Severance Hospital0 sites200 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yonsei University Health System, Yongin Severance Hospital
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A patient aged 19 years or older who was diagnosed with acute coronary syndrome and was scheduled for coronary intervention with Genoss stent.
- •\-Patients who voluntarily decided to participate in this study and consented in writing to the subject consent
Exclusion Criteria
- •\- Patients with contraindications or hypersensitivity to antiplatelet therapy
- •\- Life expectancy is less than one year
- •\- Women who are pregnant or wishing to become pregnant or women who are breastfeeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Efficacy and Safety Evaluation of Biodegradable Peripheral Stent for Iliac Artery LesionsPeripheral artery disease for iliac artery lesionsJPRN-UMIN000042238KYOTO MEDICAL PLANNING Co., Ltd.100
Recruiting
Not Applicable
Clinical outcomes following Biodegradable polymer sirolimus-eluting stent implantation for the coronary artery disease patients with diabetes mellitusDiseases of the circulatory systemKCT0005008Wonkwang University Hospital795
Completed
Not Applicable
Efficacy and safety aspects of biodegradable fixation systems: a randomised clinical trialISRCTN44212338niversity Medical Center Groningen (UMCG) (The Netherlands)230
Completed
Not Applicable
To find out effect and safety of polyethylene glycol and sodium hyaluronate in patient with dry eye diseaseCTRI/2023/02/049510Pt BD Sharma PGIMS Rohtak50
Not yet recruiting
Not Applicable
Comparison between abluminal biodegradable polymer ultrathin sirolimus-eluting stent and durable-polymer everolimus-eluting stent (GENOSS randomized clinical trial)KCT0007397Samsung Medical Center850